JP2015193657A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015193657A5 JP2015193657A5 JP2015149197A JP2015149197A JP2015193657A5 JP 2015193657 A5 JP2015193657 A5 JP 2015193657A5 JP 2015149197 A JP2015149197 A JP 2015149197A JP 2015149197 A JP2015149197 A JP 2015149197A JP 2015193657 A5 JP2015193657 A5 JP 2015193657A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical
- composition
- antiarrhythmic
- amount
- antiarrhythmic drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003416 antiarrhythmic agent Substances 0.000 claims 22
- 239000000203 mixture Substances 0.000 claims 21
- 210000003748 coronary sinus Anatomy 0.000 claims 8
- 206010003658 Atrial Fibrillation Diseases 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 5
- 206010003130 Arrhythmia supraventricular Diseases 0.000 claims 3
- 239000000443 aerosol Substances 0.000 claims 3
- 206010003662 Atrial flutter Diseases 0.000 claims 2
- 208000003734 Supraventricular Tachycardia Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 230000033764 rhythmic process Effects 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 230000007704 transition Effects 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000001871 Tachycardia Diseases 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000002565 electrocardiography Methods 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000002085 persistent effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001766 physiological effect Effects 0.000 claims 1
- 210000003492 pulmonary vein Anatomy 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000006794 tachycardia Effects 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 206010047302 ventricular tachycardia Diseases 0.000 claims 1
Claims (11)
- 患者において心房性不整脈を治療するための組成物であって、
前記組成物は、クラスIa、クラスIb、およびクラスIc抗不整脈薬からなる群から選択される有効量の少なくとも1つの薬学的抗不整脈薬を含み、前記少なくとも1つの薬学的抗不整脈薬が、最初に肺静脈を通って患者の心臓に侵入し、冠状静脈洞に到達するようにし、ここで、前記薬学的抗不整脈薬は、吸入を介して投与され、前記少なくとも1つの薬学的抗不整脈薬の量は、前記投与の開始から10秒〜30分の時点で、前記心臓の前記冠状静脈洞内でピークに達し、
ここで、吸入を介して投与された前記少なくとも1つの薬学的抗不整脈薬の放出量は、静脈内投与された同一の前記薬学的抗不整脈薬の量以下であり、前記冠状静脈洞内で前記薬学的抗不整脈薬の治療上有効量を達成することを特徴とする、組成物。 - 請求項1に記載の組成物であって、前記患者が前記投与の開始から30分以内に正常洞律動を有し、ここで、前記患者に侵入する前記少なくとも1つの薬学的抗不整脈薬の有効量が0.1mg〜500mgの範囲であり、ここで、前記心臓の前記冠状静脈洞内の前記少なくとも1つの薬学的抗不整脈薬の濃度は、投与の開始後2.5分で、0.1mg/L〜60mg/Lの範囲であり、ここで、前記心臓の前記冠状静脈洞内の前記少なくとも1つの薬学的抗不整脈薬の濃度は、投与の開始後30分で、0.1mg/L未満であるか、あるいは前記投与された少なくとも1つの薬学的抗不整脈薬の名目投与量の10%〜60%が、前記冠状静脈洞に到達する、組成物。
- 請求項1あるいは2に記載の組成物であって、ここで、前記少なくとも1つの薬学的抗不整脈薬の量は、前記投与の開始から10秒〜30分の時点で、前記心臓の前記冠状静脈洞内でピークに達し、ここで、前記心臓の前記冠状静脈洞内の前記少なくとも1つの薬学的抗不整脈薬の濃度は、投与の開始後30分で、0.1mg/L未満であるか、または前記組成物中の前記薬学的抗不整脈薬の量は0.1重量%〜100重量%である、組成物。
- 請求項1〜3のいずれかに記載の組成物であって、前記少なくとも1つの薬学的抗不整脈薬が1〜6回の吸入で投与されることを特徴とする、組成物。
- 請求項1〜4のいずれかに記載の組成物であって、ここで、前記心房性不整脈が、上室性頻拍症、発作性上室性頻拍のような頻拍、心房細動、発作性心房細動、持続性および永久的な心房細動における急性発作、心房粗動、発作性心房粗動または孤立性心房細動を含む、組成物。
- 請求項1〜5のいずれかに記載の組成物であって、前記少なくとも1つの薬学的抗不整脈薬を含む液体、乾燥粉末、凝縮エアロゾル、または噴霧溶液を含み、ここで前記粉末、エアロゾルまたは噴霧液滴が10μm未満の空気動力学的中央粒子径を有する、組成物。
- 患者において心房性不整脈を治療する組成物であって、
前記組成物が、クラスIa、クラスIb、およびクラスIc抗不整脈薬からなる群から選択される有効量の少なくとも1つの薬学的抗不整脈薬を含む前記組成物を吸入によって投与され、ここで、電気生理学的効果は、心電図検査法を介して、前記投与の開始から10秒〜30分の時点で観察されることを特徴とする、組成物。 - 請求項7に記載の組成物であって、前記電気生理学的効果は、不整脈から正常洞律動への移行を含む、組成物。
- 請求項7または8に記載の組成物であって、前記電気生理学的効果は、P波の非存在からP波の存在への移行を含む、組成物。
- 請求項1〜9のいずれかに記載の組成物であって、前記少なくとも1つの薬学的抗不整脈薬の前記有効量は、全体血液量によって希釈される場合、治療量以下である、組成物。
- 請求項1〜10のいずれかに記載の組成物であって、10μm未満の空気動力学的中央粒子径を有する粒子であって、ここで前記粒子が、少なくとも1つの薬学的抗不整脈薬を、前記冠状静脈洞内で最小有効量を達成する、静脈内投与された同一の少なくとも1つの薬学的抗不整脈薬の量以下の量で含む粒子と、
薬学的に許容される賦形剤および溶媒と、
を含むエアロゾルを含む、組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21038209P | 2009-03-18 | 2009-03-18 | |
US61/210,382 | 2009-03-18 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012500945A Division JP2012520890A (ja) | 2009-03-18 | 2010-03-18 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017123029A Division JP2017160268A (ja) | 2009-03-18 | 2017-06-23 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015193657A JP2015193657A (ja) | 2015-11-05 |
JP2015193657A5 true JP2015193657A5 (ja) | 2016-01-28 |
Family
ID=42739985
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012500945A Withdrawn JP2012520890A (ja) | 2009-03-18 | 2010-03-18 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
JP2015149197A Withdrawn JP2015193657A (ja) | 2009-03-18 | 2015-07-29 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
JP2017123029A Pending JP2017160268A (ja) | 2009-03-18 | 2017-06-23 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
JP2018204914A Active JP6715305B2 (ja) | 2009-03-18 | 2018-10-31 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
JP2019162836A Active JP7071949B2 (ja) | 2009-03-18 | 2019-09-06 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012500945A Withdrawn JP2012520890A (ja) | 2009-03-18 | 2010-03-18 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017123029A Pending JP2017160268A (ja) | 2009-03-18 | 2017-06-23 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
JP2018204914A Active JP6715305B2 (ja) | 2009-03-18 | 2018-10-31 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
JP2019162836A Active JP7071949B2 (ja) | 2009-03-18 | 2019-09-06 | 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法 |
Country Status (9)
Country | Link |
---|---|
US (5) | US8974828B2 (ja) |
EP (3) | EP3552603A1 (ja) |
JP (5) | JP2012520890A (ja) |
AU (1) | AU2010226613B2 (ja) |
CA (2) | CA2755809C (ja) |
DK (1) | DK2413902T3 (ja) |
ES (1) | ES2750359T3 (ja) |
PL (1) | PL2413902T3 (ja) |
WO (1) | WO2010107964A1 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3552603A1 (en) | 2009-03-18 | 2019-10-16 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
US9775379B2 (en) | 2010-12-22 | 2017-10-03 | Syqe Medical Ltd. | Method and system for drug delivery |
US9713687B2 (en) | 2012-08-21 | 2017-07-25 | Philip Morris Usa Inc. | Ventilator aerosol delivery system with transition adapter for introducing carrier gas |
US11191755B2 (en) | 2014-01-17 | 2021-12-07 | Cornell University | Compositions and methods for providing cardioprotective effects |
TWI590837B (zh) * | 2014-03-25 | 2017-07-11 | 林信湧 | 一種用於治療心臟病之吸入式醫藥組成物及其備製方法 |
EP3160565B1 (en) * | 2014-06-30 | 2021-08-18 | Syqe Medical Ltd. | Devices and systems for pulmonary delivery of active agents |
KR102482733B1 (ko) | 2014-06-30 | 2022-12-29 | 사이키 메디컬 엘티디. | 유동 조절 흡입기 디바이스 |
WO2016118625A1 (en) * | 2015-01-20 | 2016-07-28 | Incarda Therapeutics, Inc. | Unit aerosol doses for anticoagulation |
HUE049570T2 (hu) * | 2015-04-14 | 2020-10-28 | Milestone Pharmaceuticals Inc | Rövid hatású fenilalkilamin kalciumcsatorna-blokkoló nagymértékben vízoldható sói és ezek alkalmazása |
ES2874087T3 (es) | 2016-01-06 | 2021-11-04 | Syqe Medical Ltd | Tratamiento terapéutico con dosis bajas |
EP3411030A4 (en) * | 2016-02-01 | 2019-09-04 | InCarda Therapeutics, Inc. | COMBINING ELECTRONIC SURVEILLANCE WITH INHALATION PHARMACOLOGICAL THERAPY FOR MANAGING CARDIAC ARRHYTHMIAS WITH ATRIAL FIBRILLATION |
EP3621616A4 (en) * | 2017-05-10 | 2021-01-13 | InCarda Therapeutics, Inc. | UNIT DOSE, AEROSOLS, KITS AND METHODS FOR TREATMENT OF HEART DISEASE BY PULMONAL ADMINISTRATION |
WO2019183470A2 (en) * | 2018-03-22 | 2019-09-26 | Incarda Therapeutics, Inc. | A novel method to slow ventricular rate |
JP2021526900A (ja) * | 2018-06-05 | 2021-10-11 | インカーダ セラピューティクス, インコーポレイテッド | エアロゾルを用いるブルガダ症候群の診断方法 |
EP3806839A4 (en) * | 2018-06-14 | 2022-03-30 | Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") | COMPOSITIONS AND METHODS TO DELIVER CARDIOPROTECTIVE EFFECTS |
US11344518B2 (en) * | 2018-08-14 | 2022-05-31 | AltaThera Pharmaceuticals LLC | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame |
US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
IL303094A (en) * | 2019-08-01 | 2023-07-01 | Incarda Therapeutics Inc | Antiarrhythmic formulation |
JP2024502236A (ja) * | 2020-12-17 | 2024-01-18 | インカーダ セラピューティクス, インコーポレイテッド | 心房性不整脈を有する対象におけるカルディオバージョンの誘導のためのキットおよび方法 |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
IT1016489B (it) | 1974-03-18 | 1977-05-30 | Isf Spa | Inalatore |
SE408265B (sv) | 1975-12-12 | 1979-06-05 | Draco Ab | Anordning for koldioxiddriven endosaerosol, avsedd for inhalering |
US4247066A (en) | 1978-02-21 | 1981-01-27 | General Dynamics Corporation | Airfoil variable cambering device and method |
IT1116047B (it) | 1979-04-27 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma |
DE3634952A1 (de) | 1986-10-14 | 1988-04-21 | Bayer Ag | Imidazo-pyrrolo-pyridin-derivate |
JP3202705B2 (ja) * | 1987-11-06 | 2001-08-27 | リサーチ ディベロップメント ファンデーション | 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子 |
US4962095A (en) * | 1989-02-15 | 1990-10-09 | E. R. Squibb & Sons, Inc. | Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
ATE189124T1 (de) | 1991-07-02 | 2000-02-15 | Inhale Inc | Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
ATE264096T1 (de) | 1994-03-07 | 2004-04-15 | Nektar Therapeutics | Verfahren und mittel zur verabreichung von insulin über die lunge |
AU696387B2 (en) | 1994-05-18 | 1998-09-10 | Inhale Therapeutic Systems, Inc. | Methods and compositions for the dry powder formulation of interferons |
JP3388896B2 (ja) | 1994-08-08 | 2003-03-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
US5693609A (en) | 1994-11-17 | 1997-12-02 | Eli Lilly And Company | Acylated insulin analogs |
KR19980703876A (ko) | 1995-04-14 | 1998-12-05 | 스티븐 엘. 허스트 | 분산성이 개선된 분말화된 약학적 조성물 |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
EP0952821A4 (en) | 1996-12-31 | 2006-07-26 | Nektar Therapeutics | METHODS FOR DRYING AQUEOUS SUSPENSION OF HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS AND COMPOSITIONS PREPARED THEREFROM |
US20020017295A1 (en) | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
WO1999016420A1 (en) | 1997-09-29 | 1999-04-08 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in nebulizers |
DE69814428T2 (de) | 1997-09-29 | 2004-05-13 | Nektar Therapeutics, San Carlos | In verneblern verwendbare, stabilisierte zubereitungen |
US6541479B1 (en) * | 1997-12-02 | 2003-04-01 | Massachusetts College Of Pharmacy | Calcium channel blockers |
US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
DE19835346A1 (de) | 1998-08-05 | 2000-02-10 | Boehringer Ingelheim Pharma | Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren |
IL143046A0 (en) | 1998-11-12 | 2002-04-21 | Pilkiewicz Frank G | An inhalation system |
JP4377076B2 (ja) | 1999-05-28 | 2009-12-02 | ネクター セラピューティクス | 噴霧化された薬物の計量された量を投与する装置と方法 |
NZ521972A (en) * | 2000-04-17 | 2004-06-25 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
MXPA02001323A (es) | 2000-05-10 | 2004-07-16 | Alliance Pharma | Microgranulos con base fosfolipida para la liberacion de farmaco. |
US6357490B1 (en) | 2000-08-22 | 2002-03-19 | Advanced Inhalation Research, Inc. | System, method and apparatus for filling containers |
FI20002215A0 (fi) * | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
KR100743404B1 (ko) | 2000-12-21 | 2007-07-30 | 넥타르 테라퓨틱스 | 폴리엔 항균제의 폐 전달 |
WO2002080859A2 (en) | 2001-03-20 | 2002-10-17 | Glaxo Group Limited | Inhalation drug combinations |
US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US20080038363A1 (en) * | 2001-05-24 | 2008-02-14 | Zaffaroni Alejandro C | Aerosol delivery system and uses thereof |
CA2446904A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US20070122353A1 (en) * | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US7231919B2 (en) * | 2001-09-28 | 2007-06-19 | Kurve Technology, Inc. | Particle dispersion device for nasal delivery |
ATE418991T1 (de) * | 2002-04-18 | 2009-01-15 | Cv Therapeutics Inc | Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker |
US7334580B2 (en) | 2002-05-07 | 2008-02-26 | Smaldone Gerald C | Methods, devices and formulations for targeted endobronchial therapy |
US7607436B2 (en) | 2002-05-06 | 2009-10-27 | The Research Foundation Of State University Of New York | Methods, devices and formulations for targeted endobronchial therapy |
CA2485340C (en) | 2002-05-07 | 2015-09-29 | The State University Of New York At Stony Brook | Methods, devices and formulations for targeted endobronchial therapy |
EP1589947B2 (en) | 2002-12-31 | 2019-01-30 | Novartis AG | Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
WO2004100964A1 (en) * | 2003-04-24 | 2004-11-25 | Aderis Pharmaceuticals, Inc. | Method of treating atrial fibrillation or atrial flutter |
US7674820B2 (en) * | 2003-08-07 | 2010-03-09 | Cardiome Pharma Corp. | Ion channel modulating activity I |
CA2566174A1 (en) * | 2004-05-21 | 2005-12-01 | Transave, Inc. | Treatment of lung diseases and pre-lung disease conditions |
US8569277B2 (en) * | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
US20070086957A1 (en) | 2005-10-10 | 2007-04-19 | Thierry Bouyssou | Combination of medicaments for the treatment of respiratory diseases |
ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
KR20080057296A (ko) * | 2005-10-21 | 2008-06-24 | 머크 앤드 캄파니 인코포레이티드 | 칼륨 채널 억제제 |
CL2007002689A1 (es) * | 2006-09-18 | 2008-04-18 | Vitae Pharmaceuticals Inc | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. |
EP2668970B1 (en) | 2006-10-25 | 2016-07-06 | Novartis AG | Powder dispersion apparatus |
EP2099295A4 (en) | 2006-11-22 | 2010-02-24 | Reliant Pharmaceuticals Inc | PROPHYLAXIS AND TREATMENT OF AURICULAR FIBRILLATION WITH OMEGA-3 FATTY ACIDS |
TW200840578A (en) | 2006-12-15 | 2008-10-16 | Procter & Gamble | Compositions of azimilide dihydrochloride |
WO2008134630A1 (en) * | 2007-04-30 | 2008-11-06 | Apt Pharmaceuticals | Dexrazoxane compounds for cardioprotection |
US20080275036A1 (en) * | 2007-05-02 | 2008-11-06 | Apt Pharmaceuticals, Inc. | Prevention and treatment of cardiac conditions |
EP2323648A4 (en) | 2008-08-14 | 2012-10-03 | Uab Research Foundation | ANTI-ARTHRITIS AGENTS, METHODS FOR THEIR USE, METHODS FOR THEIR IDENTIFICATION AND RELEVANT KITS |
CA2734780C (en) * | 2008-08-22 | 2016-07-05 | Milestone Pharmaceuticals Inc. | Short acting benzothiazepine calcium channel blockers and uses thereof |
BR112012006635B8 (pt) * | 2008-09-23 | 2021-05-25 | Laboratory Skin Care Inc | composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas |
EP3552603A1 (en) | 2009-03-18 | 2019-10-16 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
-
2010
- 2010-03-18 EP EP19176305.1A patent/EP3552603A1/en active Pending
- 2010-03-18 JP JP2012500945A patent/JP2012520890A/ja not_active Withdrawn
- 2010-03-18 WO PCT/US2010/027740 patent/WO2010107964A1/en active Application Filing
- 2010-03-18 CA CA2755809A patent/CA2755809C/en active Active
- 2010-03-18 DK DK10754091.6T patent/DK2413902T3/da active
- 2010-03-18 US US13/257,249 patent/US8974828B2/en active Active
- 2010-03-18 EP EP19176272.3A patent/EP3552602A1/en active Pending
- 2010-03-18 PL PL10754091T patent/PL2413902T3/pl unknown
- 2010-03-18 CA CA2835771A patent/CA2835771C/en active Active
- 2010-03-18 ES ES10754091T patent/ES2750359T3/es active Active
- 2010-03-18 EP EP10754091.6A patent/EP2413902B1/en active Active
- 2010-03-18 AU AU2010226613A patent/AU2010226613B2/en active Active
-
2015
- 2015-02-26 US US14/632,252 patent/US10045939B2/en active Active
- 2015-07-29 JP JP2015149197A patent/JP2015193657A/ja not_active Withdrawn
-
2017
- 2017-06-23 JP JP2017123029A patent/JP2017160268A/ja active Pending
-
2018
- 2018-06-20 US US16/013,178 patent/US20180318213A1/en not_active Abandoned
- 2018-06-20 US US16/013,165 patent/US20180296480A1/en not_active Abandoned
- 2018-10-26 US US16/172,456 patent/US20190060230A1/en not_active Abandoned
- 2018-10-31 JP JP2018204914A patent/JP6715305B2/ja active Active
-
2019
- 2019-09-06 JP JP2019162836A patent/JP7071949B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015193657A5 (ja) | ||
JP2017160268A5 (ja) | ||
JP2014514271A5 (ja) | ||
JP2011522876A (ja) | 永続性心房細動を予防するためのドロネダロン | |
WO2009127974A3 (ko) | 심혈관계 질환 치료용 약제학적 제제 | |
JP2017534604A5 (ja) | ||
JP2020519628A (ja) | 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法 | |
Salloum et al. | Tadalafil prevents acute heart failure with reduced ejection fraction in mice | |
Marum et al. | Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration | |
JP5501451B2 (ja) | 咳の治療のためのテオブロミン | |
TW201002314A (en) | Use of dronedarone for the preparation of a medicament for use in the prevention of cardioversion | |
CN104000809B (zh) | 一种防治冠心病心绞痛的药物组合物及其应用 | |
Paraskevaidis et al. | Narrow QRS complex in idiopathic (fascicular) left ventricular tachycardia | |
Sungnoon et al. | Effects of garlic on the induction of ventricular fibrillation | |
WO2021022058A3 (en) | Antiarrhythmic formulation | |
Oral et al. | Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation | |
JP2017511307A5 (ja) | ||
EP2905025B1 (en) | Use of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof in pharmaceutical compositions as a neuroretinal protector | |
Paraskevaidis et al. | Schmaler QRS-Komplex bei idiopathischer (faszikulärer) linksventrikulärer Tachykardie | |
Silva et al. | Radiofrequency ablation in the treatment of focal atrial fibrillation using circumferential mapping and segmentary disconnection of pulmonary veins | |
Mason et al. | HBI-3000: A Novel Drug for Conversion of Atrial Fibrillation-Phase 1 Study Results | |
周燕 et al. | A pilot study of traditional Chinese medicine Shensong Yangxin capsule in patients with premature ventricular contractions and bradycardia | |
Kaya et al. | Adverse Cardiac Effects Of Decongestants Agents | |
CN106727610A (zh) | 一种治疗病毒性心肌炎的西药组合物及其应用 | |
Halkar et al. | Idiopathic Fascicular Ventricular Tachycardia |